Western Securities: Domestic companies are embracing outbound opportunities, with continued optimism towards high-quality small nucleic acid targets.

Small nucleic acids are currently in a phase of vigorous development, with active BD transactions. Global multinational pharmaceutical companies continue to increase their investments, and domestic firms are presented with opportunities for international expansion.

Zhitong Finance10:15

Ionis Pharmaceuticals(IONS.US) Director Sells US$5.8 Million in Common Stock

$Ionis Pharmaceuticals(IONS.US)$ Director LOSCALZO JOSEPH sold 77,289 shares of common stock on May 4, 2026 at an average price of $75.0589 for a total value of $5.8 million.Source: Announcement

Futu NewsMay 7 05:28

Unusual Options Activity: AFRM, ON and Others Attract Market Bets, AFRM V/OI Ratio Reaches 172.7

EST May 1st Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options

Futu NewsMay 2 04:30

Research Alert: CFRA Raises Rating On Shares Of Ionis Pharmaceuticals, Inc. To Buy From Hold

MT NewswiresMay 1 04:10

BofA Securities Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating

Futu NewsMay 1 01:31 · Ratings

Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Teladoc (TDOC)

TipRanksMay 1 00:40 · Ratings